Cargando…

Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials

Episodic Future Thinking (EFT) reduces delay discounting and may have the potential as a clinical tool to increase the likelihood of health-promoting behaviors. However, evaluations of EFT in clinical settings require control conditions that match the effort and frequency of cue generation, as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Jeremiah M., Bickel, Warren K., Epstein, Leonard H., Stein, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399790/
https://www.ncbi.nlm.nih.gov/pubmed/37535609
http://dx.doi.org/10.1371/journal.pone.0289478
_version_ 1785084322024259584
author Brown, Jeremiah M.
Bickel, Warren K.
Epstein, Leonard H.
Stein, Jeffrey S.
author_facet Brown, Jeremiah M.
Bickel, Warren K.
Epstein, Leonard H.
Stein, Jeffrey S.
author_sort Brown, Jeremiah M.
collection PubMed
description Episodic Future Thinking (EFT) reduces delay discounting and may have the potential as a clinical tool to increase the likelihood of health-promoting behaviors. However, evaluations of EFT in clinical settings require control conditions that match the effort and frequency of cue generation, as well as participants’ expectations of improvement. The Health Information Thinking (HIT) control addresses these issues, but how this control affects delay discounting in individuals with diabetes and obesity when utilizing diabetes-management specific health-information vignettes is unknown. Moreover, little research has explored whether EFT reduces delay discounting in individuals with type 2 diabetes. To this end, we examined the impact of EFT, HIT, and a secondary no-cue control condition (NCC; assessments as usual) on delay discounting in 434 adults with self-reported type 2 diabetes and obesity recruited using Amazon Mechanical Turk. After completing an initial screening questionnaire, eligible participants reported demographics, then were randomized to EFT, HIT, or NCC conditions. Following the generation of seven EFT or HIT cues, participants assigned to EFT or HIT conditions completed a delay discounting task while imagining EFT or HIT cues; no-cue participants completed the task without cues. EFT participants demonstrated significantly lower delay discounting levels than HIT or NCC participants; no differences in delay discounting between HIT and NCC participants were observed. These results suggest that engaging in EFT, but not diabetes-specific HIT, results in lower delay discounting in adults with type 2 diabetes and obesity. This provides further evidence for the appropriateness of the HIT control for clinical trials examining the effect of EFT on delay discounting in adults with self-reported type 2 diabetes.
format Online
Article
Text
id pubmed-10399790
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-103997902023-08-04 Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials Brown, Jeremiah M. Bickel, Warren K. Epstein, Leonard H. Stein, Jeffrey S. PLoS One Research Article Episodic Future Thinking (EFT) reduces delay discounting and may have the potential as a clinical tool to increase the likelihood of health-promoting behaviors. However, evaluations of EFT in clinical settings require control conditions that match the effort and frequency of cue generation, as well as participants’ expectations of improvement. The Health Information Thinking (HIT) control addresses these issues, but how this control affects delay discounting in individuals with diabetes and obesity when utilizing diabetes-management specific health-information vignettes is unknown. Moreover, little research has explored whether EFT reduces delay discounting in individuals with type 2 diabetes. To this end, we examined the impact of EFT, HIT, and a secondary no-cue control condition (NCC; assessments as usual) on delay discounting in 434 adults with self-reported type 2 diabetes and obesity recruited using Amazon Mechanical Turk. After completing an initial screening questionnaire, eligible participants reported demographics, then were randomized to EFT, HIT, or NCC conditions. Following the generation of seven EFT or HIT cues, participants assigned to EFT or HIT conditions completed a delay discounting task while imagining EFT or HIT cues; no-cue participants completed the task without cues. EFT participants demonstrated significantly lower delay discounting levels than HIT or NCC participants; no differences in delay discounting between HIT and NCC participants were observed. These results suggest that engaging in EFT, but not diabetes-specific HIT, results in lower delay discounting in adults with type 2 diabetes and obesity. This provides further evidence for the appropriateness of the HIT control for clinical trials examining the effect of EFT on delay discounting in adults with self-reported type 2 diabetes. Public Library of Science 2023-08-03 /pmc/articles/PMC10399790/ /pubmed/37535609 http://dx.doi.org/10.1371/journal.pone.0289478 Text en © 2023 Brown et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Brown, Jeremiah M.
Bickel, Warren K.
Epstein, Leonard H.
Stein, Jeffrey S.
Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials
title Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials
title_full Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials
title_fullStr Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials
title_full_unstemmed Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials
title_short Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials
title_sort episodic future thinking in type 2 diabetes: further development and validation of the health information thinking control for clinical trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399790/
https://www.ncbi.nlm.nih.gov/pubmed/37535609
http://dx.doi.org/10.1371/journal.pone.0289478
work_keys_str_mv AT brownjeremiahm episodicfuturethinkingintype2diabetesfurtherdevelopmentandvalidationofthehealthinformationthinkingcontrolforclinicaltrials
AT bickelwarrenk episodicfuturethinkingintype2diabetesfurtherdevelopmentandvalidationofthehealthinformationthinkingcontrolforclinicaltrials
AT epsteinleonardh episodicfuturethinkingintype2diabetesfurtherdevelopmentandvalidationofthehealthinformationthinkingcontrolforclinicaltrials
AT steinjeffreys episodicfuturethinkingintype2diabetesfurtherdevelopmentandvalidationofthehealthinformationthinkingcontrolforclinicaltrials